
LA Mika 250mg Injection
Marketer
Zuventus Healthcare Ltd
Salt Composition
Amikacin (250mg)
Overview LA Mika 250mg Injection
Cefamika 250mg Injection, an antibiotic medication, combats a broad spectrum of bacterial infections. These can affect various body systems, including the urinary tract, bones, joints, respiratory system (such as pneumonia), central nervous system, and bloodstream. Prophylactic use in hospitalized patients is also common. Cefamika 250mg Injection's mechanism involves inhibiting bacterial growth. Administered intravenously (IV infusion) or intramuscularly by a healthcare professional only, self-administration is strictly prohibited. Adherence to the prescribed dosage schedule is crucial; consistent, evenly spaced intervals are necessary. Complete the entire course, even with symptom improvement, to avoid relapse or infection exacerbation. Commonly reported side effects include injection site reactions and elevated blood urea nitrogen levels. Persistent side effects or lack of improvement warrant immediate medical attention. High doses may rarely cause vertigo, renal impairment, and hearing difficulties. Strict adherence to physician instructions is vital, including regular monitoring of kidney function, hearing, and urine analysis. This medication is contraindicated during pregnancy. Disclose pregnancy, pregnancy planning, or breastfeeding to your doctor.
Uses of LA Mika 250mg Injection
Infections caused by bacteria
Major Benefits of LA Mika 250mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strongly discouraged.
Common Side effects of LA Mika 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use LA Mika 250mg Injection:
Administering this medication will be handled by your physician or their assigned nurse; self-medication is strictly prohibited.
How LA Mika 250mg Injection works:
Mika 250mg Injection is a bacterial infection treatment. Its antibiotic action halts bacterial proliferation by inhibiting the production of crucial proteins necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from using LA Mika 250mg Injection concurrently with alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering LA Mika 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
LA Mika 250mg Injection poses minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, posing no discernible harm to the infant.
DrivingUNSAFE
Administration of LA Mika 250mg Injection can induce drowsiness, visual disturbances, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Exercise caution when administering LA Mika 250mg Injection to individuals with impaired renal function. Dosage modification of LA Mika 250mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of LA Mika 250mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may not be necessary. Physician consultation is recommended.
What if you forget to take LA Mika 250mg Injection :
Should you forget a scheduled dose of LA Mika 250mg Injection, seek medical advice.
Facts to Know About LA Mika 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
| Actions | Aminoglycoside antibiotics |
